Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
HIV Medicine ; 24(Supplement 3):71, 2023.
Article in English | EMBASE | ID: covidwho-2324764

ABSTRACT

Background: England is committed to ending HIV transmission by 2030. The HIV Action Plan (2021) set an interim ambition to reduce HIV transmission by 80% to 600 new diagnoses first made in England by 2025. Here we present the progress between 2019 (baseline) and 2021, interpreted in the context of the COVID-19 pandemic. Method(s): People newly diagnosed with HIV were reported to the HIV and AIDS Reporting Section (HARS). The annual number of people having an HIV test in all sexual health services (SHS) including online testing were reported using GUMCAD. HIV diagnoses among people previously diagnosed abroad were excluded (25%). Result(s): New HIV diagnoses first made in England fell by 32% from 2,986 in 2019 to 1,987 in 2020, but plateaued in 2021 (2,023). Among gay/bisexual men, HIV diagnoses plateaued in 2021 (721) after a fall of 45% between 2019 and 2020, from 1,262 to 699. After a fall in HIV testing in 2020 (from 156,631 in 2019 to 144,800 in 2020), the number of people tested in 2021 (178,466) exceeded pre-COVID-19 levels. This suggests a decline in HIV incidence supported by a CD4 back calculation model (80% probability of a decline for the period 2019-2021), but at a slowing rate. Among heterosexual adults, new HIV diagnoses first made in England in 2021 also plateaued (798) following a 31% decrease (from 1,109 in 2019 to 761 in 2020). However, HIV testing coverage has not recovered to pre- COVID-19 levels (628,607 in 2019, 441,017 in 2020 and 489,727 in 2021). This provides no evidence of a fall in incidence in this population. Conclusion(s): A reduction by 360 new diagnoses first made in England year on year from 2022 onwards is required to meet the HIV Action Plan ambition. Despite an estimated 4,500 people with undiagnosed HIV and extremely high levels of antiretroviral therapy and viral suppression, PrEP access remains unequal. HIV testing numbers, which were affected by COVID-19 pandemic, have recovered in gay/bisexual men, but not among heterosexual adults. While the interim ambition is within reach for gay/bisexual men, PrEP and testing levels must be scaled up in heterosexual adults.

2.
HIV Medicine ; 24(Supplement 3):68-69, 2023.
Article in English | EMBASE | ID: covidwho-2326196

ABSTRACT

Background: The National HIV Mortality Review (NHMR) was launched by UK Health Security Agency (UKHSA) and British HIV Association to better recognise causes of death and preventable death, and to describe end-of-life care, among people with HIV. Method(s): UK HIV services submitted data on all known deaths among people with HIV under their care in 2021 through a secure online form. Cause of death was categorised by an epidemiologist and four clinicians using the Coding Causes of Death in HIV protocol. Result(s): In 2021, 101 services reported 606 deaths among people with HIV to NHMR. In 2019, 74 services reported to the NHMR while 121 reported in 2020. Median age at death was 58 [interquartile range (IQR): 56-59] and most (76%) were male. Death cause was ascertainable for 78% (n=475), with the most common being non-AIDS-related cancers (26%), followed by non-AIDS-defining infections (19%), cardiovascular disease (16%), AIDS (9%), substance misuse (8%), respiratory disease (4%), accident/suicide (3%), liver disease (2%) and other causes (11%). COVID- 19 caused or contributed to 11% of all deaths. Thirtythree people (5%) died within a year of HIV diagnosis, 90% of these were diagnosed late (CD4<350 cells/mm3), 80% very late (CD4<200 cells/mm3), 54% diagnosed with AIDS and 33% had documented missed opportunities for earlier diagnosis. Viral suppression (<200 copies/mL) (87%) and treatment coverage (98%) was high with the median time on treatment 13 years [IQR: 8-20]. Common lifestyle risk factors in the preceding year included smoking (33%;n=179), excessive alcohol use (20%;n=103). Other factors included drug use (non-injecting and injecting) and opioid substitution therapy. Death had been expected for 298 (49%) individuals, of whom 230 had discussed end-of-life care and 108 had a documented advanced end-of-life care plan in place. Conclusion(s): Over half of people living with diagnosed HIV are aged over 50. Most deaths were not AIDS related however, one in eleven people with diagnosed HIV in the UK died from AIDS. Of people that died within a year of diagnosis, one in three had documented missed opportunities for earlier HIV diagnosis.

3.
12th International Conference on Construction in the 21st Century, CITC 2022 ; 2022.
Article in English | Scopus | ID: covidwho-2287883

ABSTRACT

Travel restrictions have been imposed among countries since the outbreak of the COVID-19 pandemic. Time delays, budget issues, and poor-quality control in construction projects due to the pandemic have severely affected the construction industry. To reduce the influence of the pandemic, the paper introduces an offshore construction site progress management system with a real case study. With the integration of indoor location-based service technology and image processing method, site superintendents (architect, project director, site manager, engineer) can monitor the site progress easily and pinpoint defects for further investigation and measurement. The visualization of site images together with BIM provides a digital twin platform that can help senior management quickly review the site progress, perform quality checks, and resolve discrepancies in early phases. Positioning of workers and equipment with the adoption of digital maps is a further step in sustainable management. The proposed integration provides a new concept for construction site management during a pandemic and supports the post-COVID-19 new normal in the construction industry. © 2022 International Conference on Construction in the 21st Century. All rights reserved.

4.
Universidad Medica Pinarena ; 18(1), 2022.
Article in Spanish | CAB Abstracts | ID: covidwho-1897996

ABSTRACT

Introduction: Coronavirus disease 2019 mainly affects the respiratory system, however, various clinical studies have shown that the coronavirus family has a certain tropism for the nervous system.

5.
Hiv Medicine ; 23:18-19, 2022.
Article in English | Web of Science | ID: covidwho-1820631
SELECTION OF CITATIONS
SEARCH DETAIL